Literature DB >> 26267085

Serum concentrations of canine interleukin-1 receptor antagonist protein in healthy dogs after incubation using an autologous serum processing system.

S S Huggins1, J S Suchodolski2, R N Bearden1, J M Steiner2, W B Saunders3.   

Abstract

The objectives of this study were to optimize and validate a canine IL-1RA ELISA using commercially available reagents and to determine the effect of an autologous serum processing system (IRAP II) on IL-1RA concentrations in canine serum. The clinical detection limit of the optimized ELISA was 188.8 to 39,965.6 pg/mL. The observed-to-expected ratio (O:E) for three serial dilutions for four serum samples ranged from 109.6 to 132.2%. The O:E for four serum samples spiked with four concentrations of canine IL-1 RA ranged from 98.7 to 114.3%. Coefficients of variances for intra- and interassay variability ranged from 1.4 to 3.0 and 6.3 to 9.8, respectively. The ELISA was sensitive, linear, accurate, precise, and reproducible. Mean±SD serum concentration of IL-1RA in 12 healthy dogs was 396.6±208.0 pg/mL. There was a significant increase in IL-1RA when blood was incubated in the IRAP II system (15,955.0±6421.0 pg/mL, P<0.0001). Published by Elsevier Ltd.

Entities:  

Keywords:  Autologous serum; Canine interleukin-1 receptor antagonist; ELISA; Orthobiologics; Osteoarthritis

Mesh:

Substances:

Year:  2015        PMID: 26267085     DOI: 10.1016/j.rvsc.2015.05.012

Source DB:  PubMed          Journal:  Res Vet Sci        ISSN: 0034-5288            Impact factor:   2.534


  3 in total

1.  In Vitro Anti-Inflammatory and Regenerative Effects of Autologous Conditioned Serum from Dogs with Osteoarthritis.

Authors:  Sirikul Soontararak; Piyathida Ardaum; Napaporn Senarat; Sarawut Yangtara; Chalermpol Lekchareonsuk; Iyarath Putchong; Narudee Kashemsant; Monchanok Vijarnsorn; Lyndah Chow; Steven Dow; Porntippa Lekchareonsuk
Journal:  Animals (Basel)       Date:  2022-10-10       Impact factor: 3.231

Review 2.  Cell-Based Therapies for Joint Disease in Veterinary Medicine: What We Have Learned and What We Need to Know.

Authors:  Sophie Helen Bogers
Journal:  Front Vet Sci       Date:  2018-04-16

3.  Cytokine-induced interleukin-1 receptor antagonist protein expression in genetically engineered equine mesenchymal stem cells for osteoarthritis treatment.

Authors:  Simone Gabner; Reinhard Ertl; Karsten Velde; Matthias Renner; Florien Jenner; Monika Egerbacher; Juraj Hlavaty
Journal:  J Gene Med       Date:  2018-04-22       Impact factor: 4.565

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.